Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free AFIB Stock Alerts

Acutus Medical (AFIB) Competitors

Acutus Medical logo
$0.0003 0.00 (0.00%)
As of 10:52 AM Eastern
Compare

AFIB vs. GMVDF, SDCCQ, VRAYQ, WOK, and TTOO

Should you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include G Medical Innovations (GMVDF), SmileDirectClub (SDCCQ), ViewRay (VRAYQ), WORK Medical Technology Group (WOK), and T2 Biosystems (TTOO). These companies are all part of the "medical equipment" industry.

How does Acutus Medical compare to G Medical Innovations?

Acutus Medical (NASDAQ:AFIB) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Acutus Medical has a beta of 6.03, suggesting that its stock price is 503% more volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 43.14, suggesting that its stock price is 4,214% more volatile than the S&P 500.

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 5.2% of Acutus Medical shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
G Medical Innovations N/A N/A N/A

G Medical Innovations has lower revenue, but higher earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
G Medical Innovations$4.42M0.21-$24.63MN/AN/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
G Medical Innovations Neutral

Summary

G Medical Innovations beats Acutus Medical on 7 of the 9 factors compared between the two stocks.

How does Acutus Medical compare to SmileDirectClub?

Acutus Medical (NASDAQ:AFIB) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Acutus Medical has higher earnings, but lower revenue than SmileDirectClub. Acutus Medical is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
SmileDirectClub Neutral

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

SmileDirectClub has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. SmileDirectClub's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
SmileDirectClub N/A N/A N/A

Acutus Medical has a beta of 6.03, indicating that its stock price is 503% more volatile than the S&P 500. Comparatively, SmileDirectClub has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.

Summary

SmileDirectClub beats Acutus Medical on 6 of the 11 factors compared between the two stocks.

How does Acutus Medical compare to ViewRay?

Acutus Medical (NASDAQ:AFIB) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
ViewRay Neutral

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 15.5% of ViewRay shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 2.5% of ViewRay shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Acutus Medical has higher earnings, but lower revenue than ViewRay. Acutus Medical is trading at a lower price-to-earnings ratio than ViewRay, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
ViewRay$102.21M0.00-$107.33M-$0.31N/A

Acutus Medical has a beta of 6.03, indicating that its stock price is 503% more volatile than the S&P 500. Comparatively, ViewRay has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500.

ViewRay has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. ViewRay's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
ViewRay N/A N/A N/A

Summary

Acutus Medical and ViewRay tied by winning 5 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to WORK Medical Technology Group?

Acutus Medical (NASDAQ:AFIB) and WORK Medical Technology Group (NASDAQ:WOK) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

WORK Medical Technology Group has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. WORK Medical Technology Group's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
WORK Medical Technology Group N/A N/A N/A

56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, WORK Medical Technology Group had 2 more articles in the media than Acutus Medical. MarketBeat recorded 2 mentions for WORK Medical Technology Group and 0 mentions for Acutus Medical. WORK Medical Technology Group's average media sentiment score of 1.00 beat Acutus Medical's score of 0.00 indicating that WORK Medical Technology Group is being referred to more favorably in the news media.

Company Overall Sentiment
Acutus Medical Neutral
WORK Medical Technology Group Positive

Acutus Medical has a beta of 6.03, indicating that its share price is 503% more volatile than the S&P 500. Comparatively, WORK Medical Technology Group has a beta of 2.37, indicating that its share price is 137% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acutus Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

WORK Medical Technology Group has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
WORK Medical Technology Group$9.81M0.00-$1.07MN/AN/A

Summary

WORK Medical Technology Group beats Acutus Medical on 9 of the 12 factors compared between the two stocks.

How does Acutus Medical compare to T2 Biosystems?

Acutus Medical (NASDAQ:AFIB) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Acutus Medical has a net margin of -272.74% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
T2 Biosystems -563.16%N/A -174.06%

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
T2 Biosystems Neutral

T2 Biosystems has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than T2 Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A

56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Acutus Medical has a beta of 6.03, suggesting that its share price is 503% more volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 8.16, suggesting that its share price is 716% more volatile than the S&P 500.

Summary

T2 Biosystems beats Acutus Medical on 6 of the 11 factors compared between the two stocks.

Get Acutus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFIB vs. The Competition

Export
MetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$9K$46.11M$6.25B$11.87B
Dividend YieldN/A1.08%2.73%5.21%
P/E Ratio0.0018.5829.0428.48
Price / Sales0.0030.72476.4860.89
Price / CashN/A18.8827.6236.52
Price / Book-0.0114.279.676.67
Net Income-$81.66M-$20.10M$3.55B$332.64M
7 Day PerformanceN/A-1.39%1.70%2.01%
1 Month PerformanceN/A-1.61%5.62%9.19%
1 Year PerformanceN/A10.93%34.42%39.59%

Acutus Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFIB
Acutus Medical
N/A$0.00
flat		N/AN/A$9K$7.16MN/A340
GMVDF
G Medical Innovations
N/A$0.00
flat		N/AN/A$52K$4.42MN/A72
SDCCQ
SmileDirectClub
N/A$0.00
-90.0%		N/AN/A$40K$470.74MN/A2,700
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300
WOK
WORK Medical Technology Group
N/A$1.17
-2.5%		N/AN/A$12K$9.81MN/A226

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AFIB) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel